Sign Up to like & get
recommendations!
0
Published in 2021 at "ACS applied materials & interfaces"
DOI: 10.1021/acsami.0c21996
Abstract: Grafting biomolecules on nanostructures' surfaces is an increasingly used strategy to target pathogenic cells, with both diagnostic and therapeutic applications. However, nanomaterials monofunctionalized by conjugating a single type of ligand find limited uses in pathologies/therapies…
read more here.
Keywords:
antibody conjugated;
antibody;
conjugated amyloid;
dual antibody ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Cancer immunology research"
DOI: 10.1158/2326-6074.tumimm18-b49
Abstract: The survival benefit of checkpoint immunotherapies is currently limited, with de novo and acquired resistance to therapy occurring in over 75% of patients. A major mechanism of resistance accounting for these poor responses is a…
read more here.
Keywords:
ca9;
immunology;
dual antibody;
cell ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Bioengineering and Biotechnology"
DOI: 10.3389/fbioe.2022.806238
Abstract: Circulating tumor cells (CTCs) have been well-established as promising biomarkers that can be leveraged to gauge the prognosis of patients with cancers and to guide patient treatment efforts. Although the scarcity of CTCs within peripheral…
read more here.
Keywords:
circulating tumor;
tumor cells;
release;
capture ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.795209
Abstract: About 5% of B cells in healthy mice and humans are allelically or isotypically included and hence co-express two different antibodies. In mice, dual antibody B cells (B2R) expand with systemic autoimmunity, co-express autoreactive and…
read more here.
Keywords:
b2r cells;
cell reactive;
antibody cells;
reactive vh4 ... See more keywords